Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy

Journal of Clinical Oncology

Volumn 19, Issue 18, 2001, Pages 3848-3851

  Holkova, B ^a   Takeshita, K ^a   Cheng, D M ^a   Volm, M ^a   Wasserheit, C ^a   Demopoulos, R ^a   Chanan Khan, A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LUNG TUMOR; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 0035884224     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.18.3848     Document Type: Article

References (25)

1. Cancer trends in a population at risk of acquired immunodeficiency syndrome
2. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma
3. The epidemiology of AIDS-related neoplasms
4. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less: AIDS Clinical Trials Group 320 Study Team
5. The effects on survival of early treatment of human immunodeficiency virus infection
6. Decline in morbidity and opportunistic diseases with combination antiretroviral therapy
7. The epidermologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma
8. Decline in HIV-associated Kaposi's sarcoma (KS), and non-Hodgkin's lymphoma (NHL) following the introduction of highly active antiretroviral therapy, 3rd National AIDS Malignancy Conference
9. Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome
10. Pulmonary Kaposi's sarcoma: Clinical findings and results of therapy
11. Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma
12. Pulmonary manifestations of Kaposi's sarcoma
13. Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome: Clinical, radiographic and pathologic manifestations
14. Pegylated-liposomal doxombicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
15. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma
16. Patients with AIDS-related pulmonary Kaposi's sarcoma (PKS) treated with highly active antiretroviral therapy (HAART) alone after induction with systemic chemotherapy, Third National AIDS Malignancy Conference
17. Regression of invasive AIDS-related Kaposi's sarcoma following antiretroviral therapy
18. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy
19. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor
20. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
21. The decline in CD4+ T lymphocytes as a function of the duration of HIV infection, age at seroconversion, and viral load
22. Correlation between CD4 cell counts and cellular and plasma viral load in HIV-1-seropositive individuals
23. Combination antiretroviral therapy and incidence of AIDS-related malignancies
24. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma
25. AIDS-related Kaposi's sarcoma: A phase II study of liposomal doxorubicin - The TLC D-99 Study Group